News & Media

Events
Interim Report, January - June 2021

Read more
Events
ABGSC Life Science Summit

Read more
Press release
Resolutions at the Annual General Meeting in Medivir on 5 May 2021

Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing director...

Read more
Press release
MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2021

January – March Financial summary for the quarter Net turnover amounted to SEK 9.9 (7.3) million. The loss before interest, tax,...

Read more
Press release
Medivir to participate at the Kempen Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at the virtual meeting Kempen Life...

Read more
Press release
Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient has undergone the safety follow-up to identify...

Read more
Press release
Medivir appoints Magnus Christensen as interim CEO

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today that its Board of Directors appoints Magnus Christensen, the company’s CFO,...

Read more
Press release
Medivir 2020 Annual Report published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2020 now is available at the...

Read more
Press release
Number of shares and votes in Medivir

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes in Medivir has changed during...

Read more
Press release
Notice of Annual General Meeting of Medivir AB (publ)

The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the annual...

Read more
Press release
Last patient with liver cancer included in the monotherapy part of Medivir's phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient with advanced liver cancer has been included...

Read more
Press release
Changes in Medivir’s management and Board of Directors

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that Yilmaz Mahshid leaves the position as CEO of Medivir. The...

Read more